glp-1 agonist or antagonist Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data The Beneficial Effects of GLP-1
Description
Yamada at Akita University 26
has received consulting and speaker honoraria from AstraZeneca, Eli Lilly, Merck, Sharp & Dohme, Novo Nordisk, Sanofi and Servier
May have higher risk of GI or metabolic side effects
Prospective population based survey of outcome of pregnancy in diabetic women: results of the Northern Diabetic Pregnancy Audit, 1994
Its especially helpful for first-time GLP-1 users
However, it's important to note that many of these studies are observational and do not prove that GLP-1 medications cause the reduced risk
